Cancer Pain (Treatment)

Gabapentin: Effective Adjuvant for Cancer Pain

Published in Cancer Weekly, August 9th, 1999

Gabapentin shows promise as an adjuvant analgesic to opioid therapy for neuropathic cancer pain.

Augusto Caraceni, MD, of the National Cancer Institute of Milan, Italy, and his colleagues administered adjuvant gabapentin therapy with positive results to 22 patients with neuropathic cancer pain not fully controlled by opioids ("Gabapentin as an Adjuvant to Opioid Analgesia for Neuropathic Cancer Pain," Journal of Pain and Symptom Management, June 1999;17(6):441-445).

Gabapentin, the researchers explained, may interfere with opioid resistance mechanisms, among other qualities, according to research data (Mao et al., Pain, 1995;62:259-274).

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1999-08-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry